Trupanion, Inc. (NASDAQ:TRUP) Receives Average Rating of "Moderate Buy" from Analysts

Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the seven analysts that are presently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $51.80.

A number of research analysts have issued reports on the stock. Piper Sandler reduced their target price on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research note on Thursday, February 20th. Stifel Nicolaus dropped their target price on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a report on Thursday, February 20th. Finally, Lake Street Capital dropped their target price on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a report on Friday, May 2nd.

Insider Activity at Trupanion

In related news, insider Brenna Mcgibney sold 5,000 shares of Trupanion stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $32.99, for a total transaction of $164,950.00. Following the completion of the transaction, the insider now directly owns 3,738 shares of the company's stock, valued at $123,316.62. This trade represents a 57.22% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Margaret Tooth sold 4,000 shares of the business's stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $37.17, for a total transaction of $148,680.00. Following the completion of the transaction, the chief executive officer now directly owns 118,784 shares of the company's stock, valued at approximately $4,415,201.28. This represents a 3.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,792 shares of company stock worth $1,122,802. 5.50% of the stock is owned by insiders.

Hedge Funds Weigh In On Trupanion

A number of institutional investors have recently modified their holdings of the stock. Barclays PLC grew its holdings in Trupanion by 259.2% during the third quarter. Barclays PLC now owns 65,498 shares of the financial services provider's stock valued at $2,750,000 after purchasing an additional 47,262 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of Trupanion by 2.7% in the third quarter. JPMorgan Chase & Co. now owns 28,317 shares of the financial services provider's stock valued at $1,189,000 after buying an additional 738 shares during the period. Ameritas Advisory Services LLC acquired a new position in shares of Trupanion in the fourth quarter valued at approximately $389,000. Bartlett & CO. Wealth Management LLC bought a new stake in Trupanion during the fourth quarter worth $266,000. Finally, KBC Group NV bought a new stake in Trupanion during the fourth quarter worth $75,000.

Trupanion Stock Performance

Trupanion stock opened at $45.02 on Tuesday. Trupanion has a 12-month low of $25.90 and a 12-month high of $57.90. The company has a market capitalization of $1.93 billion, a price-to-earnings ratio of -195.74, a price-to-earnings-growth ratio of 6.02 and a beta of 1.72. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The firm's fifty day moving average price is $36.92 and its 200 day moving average price is $44.43.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.02. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The company had revenue of $341.98 million during the quarter, compared to the consensus estimate of $337.81 million. During the same quarter in the previous year, the firm earned ($0.16) EPS. The company's revenue was up 11.7% on a year-over-year basis. On average, research analysts forecast that Trupanion will post 0.13 EPS for the current fiscal year.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.